During her tenure at PhRMA, Ms. Ventimiglia developed policy to support passage of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. In particular, she crafted policies on patient access issues, including formulary development, pharmacy and therapeutics committees, and grievance and appeal rights. Additionally, Ms. Ventimiglia served as the primary analyst handling all Medicaid issues, including the interaction between the Medicare and Medicaid programs. Ms. Ventimiglia previously worked on Medicaid and pharmaceutical issues at the National Governors Association (NGA) from 1999 to 2002. While at NGA, Ms. Ventimiglia worked directly with Governors and their policy advisors to implement state pharmaceutical assistance programs and to devise Medicaid pharmaceutical benefits. At NGA, Ms. Ventimiglia wrote several issue briefs on state pharmacy programs, organized educational conferences for Governors policy advisors, and testified on behalf of NGA before state legislative committees. Prior to NGA, she held legislative positions in the offices of both U.S. Senator Olympia J. Snowe (R-ME) and U.S. Congressman Elton Gallegly (R-CA). « less
Business Positions
Jeffrey J Kimbell and Associates
Lobbying / Policy Firm
Astellas Pharma USA
Pharmaceutical company
In The Office Of
Elton W Gallegly
US Representative from California
Olympia Jean Snowe
US Senator and Representative from Maine
Margaret Scafati Roukema
US Representative from New Jersey
Other Positions & Memberships
Education
Services/Transactions
1-10 of 16 :: see all
Boston Scientific Corp
manufacturer of medical devices
Antigenics
Biotechnology company developing cancer vaccines and other treatments...
Molecular Insight Pharmaceuticals
biopharmaceutical company specializing in...
American Community Cancer Centers
Non-profit oncology organization
Gambro AB
Globally preferred partner among patients and healthcare providers...
Navigant Biotechnologies
A wholly-owned subsidiary of CaridianBCT, Inc.
Reliant Pharmaceuticals
Pharmaceutical company purchased by GlaxoSmithKline.
AmerisourceBergen
Health Care Distribution
Roche Holdings
Pharmaceutical company - world’s biggest maker of cancer drugs
